I-Mab Biopharma
IMAB
#9316
Rank
A$0.10 B
Marketcap
$1.26
Share price
-5.65%
Change (1 day)
-54.11%
Change (1 year)

I-Mab Biopharma (IMAB) - P/B ratio

P/B ratio as of April 2025 : 0.3284

According to I-Mab Biopharma's latest financial reports the company has a price-to-book ratio of 20.1836.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

I-Mab Biopharma - P/B ratio (from 2024 to 2023)

P/B ratio by year

Year P/B ratio Change
2024-12-310.3565-92.21%
2023-12-314.57-19.47%
2022-12-315.68-83.17%
2021-12-3133.731.81%
2020-12-3125.6
2019-12-31N/A
2018-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
3.48 958.36%๐Ÿ‡บ๐Ÿ‡ธ USA
0.8189 149.36%๐Ÿ‡บ๐Ÿ‡ธ USA